tradingkey.logo

Champions Oncology Inc

CSBR
查看详细走势图
7.220USD
0.000
收盘 12/19, 16:00美东报价延迟15分钟
99.55M总市值
33.44市盈率 TTM

Champions Oncology Inc

7.220
0.000
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

+7.44%

1月

+6.65%

6月

-12.91%

今年开始到现在

-15.75%

1年

-3.80%

查看详细走势图

TradingKey Champions Oncology Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Champions Oncology Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名50/404位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价12.00。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Champions Oncology Inc评分

相关信息

行业排名
50 / 404
全市场排名
146 / 4582
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 1 位分析师
买入
评级
12.000
目标均价
+91.69%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Champions Oncology Inc亮点

亮点风险
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
业绩增长期
公司处于发展阶段,最新年度总收入56.94M美元
业绩转盈
公司业绩转盈,最新年度盈利美元
估值高估
公司最新PE估值33.44,处于3年历史高位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值333.26K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.11

Champions Oncology Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Champions Oncology Inc简介

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
公司代码CSBR
公司Champions Oncology Inc
CEOBrainin (Robert)
网址https://championsoncology.com

常见问题

Champions Oncology Inc(CSBR)的当前股价是多少?

Champions Oncology Inc(CSBR)的当前股价是 7.220。

Champions Oncology Inc的股票代码是什么?

Champions Oncology Inc的股票代码是CSBR。

Champions Oncology Inc股票的52周最高点是多少?

Champions Oncology Inc股票的52周最高点是11.990。

Champions Oncology Inc股票的52周最低点是多少?

Champions Oncology Inc股票的52周最低点是5.592。

Champions Oncology Inc的市值是多少?

Champions Oncology Inc的市值是99.55M。

Champions Oncology Inc的净利润是多少?

Champions Oncology Inc的净利润为4.70M。

现在Champions Oncology Inc(CSBR)的股票是买入、持有还是卖出?

根据分析师评级,Champions Oncology Inc(CSBR)的总体评级为买入,目标价格为12.000。

Champions Oncology Inc(CSBR)股票的每股收益(EPS TTM)是多少

Champions Oncology Inc(CSBR)股票的每股收益(EPS TTM)是0.216。
KeyAI